Filter by: Subject

Filter by: Subject

Results Per Page:

Positron emission tomography (PET) (7)
Prostate-specific membrane antigen (PSMA) (4)
Infection (3)
PET/CT (3)
Prostate cancer (3)
68Ga (2)
68Ga-PSMA (2)
Antimicrobial peptide (AMP) (2)
Biodistribution (2)
DOTA (2)
Infection imaging (2)
Microemulsion (2)
NODAGA (2)
Positron emission tomography/computed tomography (PET/CT) (2)
Radiolabeling (2)
Radiotracers (2)
Ubiquicidin (2)
68Ga labeling (1)
68Ga-DKFZ-PSMA-11 (1)
68Ga-HBED-CC-(Ahx)Lys-NH-CO-NH-Glu (1)
68Ga-NOTA-UBI (1)
68Ga-PSMAHBED (1)
68Ga/68Ge generator (1)
68Gallium (1)
68Ga‐PSMA‐617 (1)
68Ge/68Ga generator (1)
[213Bi]Bi-1,4,7,10- tetraazacyclododecane-1,4,7,10-tetraacetic acid-[Thi8 , Met(O2 ) 11]-Substance-P (1)
[68Ga]Ga-PSMA-617-ME (1)
[68Ga]Ga1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-[Thi8 , Met(O2 ) 11]-Substance-P (1)
[89Zr]IIIB6 (1)
Alpha(nu)beta(3)-integrin (1)
Angiogenesis (1)
Antibiotic-derived PET (1)
Antimicrobial peptides (1)
Bacteria (1)
Black South-African (BSAs) (1)
Breast cancer (1)
Cardiac implantable electronic device (CIED) (1)
Cathelicidin (1)
Cathelicidin-derived peptide (CDP1) (1)
CDP1 (1)
Computerized tomography (CT) (1)
Depsidomycin-derived compounds (1)
Depsipeptides (1)
Diagnosis (1)
DOTA-Substance P (1)
DOTA-TBIA101 (1)
Drug carrier system (1)
Fluorine-18 ubiquicidin (1)
Gallium-68 (1)
Gallium-68 (Ga-68) (1)
Gallium-68 ubiquicidin (1)
Genotoxicity (1)
Iinfection imaging (1)
Imaging of infection (1)
In vitro (1)
In vivo (1)
In vivo toxicity (1)
Infection-selective tracers (1)
Infectious diseases (1)
Infective endocarditis (1)
Inflamation (1)
Inflammation (1)
Kit preparation (1)
Left ventricular assist device (1)
LL37 (1)
Lung cancer (1)
Medicine (1)
Micro-PET/CT imaging (1)
MicroPET/CT (1)
Molecular imaging (1)
Nimotuzumab (1)
NOTA (1)
Nota-RGD (1)
OECD guidelines (1)
Omega-3-acid ethyl esters (1)
Peptide radiolabeling (1)
PET/CT imaging (1)
PET/CT-imaging (1)
Plasmodium falciparum (1)